B. . Strober, “Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 4 Years in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials”, J of Skin, vol. 8, no. 4, p. s407, Jul. 2024.